CGEM
Cullinan Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.49
-0.46 ▼ -3.30%
🌙 3월 13일 7:29 PM ET (한국 3/14 08:29)
$13.50
+0.01 ▲ +0.07%
| Index | RUT | P/E | - | EPS (ttm) | -3.72 | Insider Own | 26.68% | Shs Outstand | 0.06B | Perf Week | -14.29% |
| Market Cap | 0.82B | Forward P/E | - | EPS next Y | 7.21% | Insider Trans | 12.24% | Shs Float | 0.04B | Perf Month | 12.79% |
| Enterprise Value | 0.44B | PEG | - | EPS next Q | -0.85 | Inst Own | 80.89% | Short Float | 18.21% | Perf Quarter | 8.27% |
| Income | -0.22B | P/S | - | EPS this Y | 8.56% | Inst Trans | 2.31% | Short Ratio | 9.77 | Perf Half Y | 103.78% |
| Sales | 0.00B | P/B | 1.99 | EPS next 5Y | 7.52% | ROA | -41.04% | Short Interest | 8.08M | Perf YTD | 30.34% |
| Book/sh | 6.78 | P/C | 2.16 | EPS past 3/5Y | - -25.62% | ROE | -44.02% | 52W High | -19.41% ($16.74) | Perf Year | 51.23% |
| Cash/sh | 6.24 | P/FCF | - | Sales past 3/5Y | - | ROIC | -53.55% | 52W Low | 137.5% ($5.68) | Perf 3Y | 22.64% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -18.75% | Gross Margin | - | Volatility(W/M) | 7.59% 7.67% | Perf 5Y | -71.93% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.25 | EPS Q/Q | -5.31% | Profit Margin | - | RSI (14) | 45.8 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.25 | Sales Q/Q | - | SMA20 | -6.45% ($14.42) | Beta | -0.12 | Target Price | $32 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | 6.53% ($12.66) | Rel Volume | 0.86 | Prev Close | $13.95 |
| Employees | 109 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 4.87% -100% | SMA200 | 44.88% ($9.31) | Avg Volume(3M) | 0.83M | Price | $13.49 |
| IPO | 2021/1/8 | Option/Short | Yes/Yes | Trades | 8154 | Volume | 707,409 | Change | -3.3% |
뉴스 로딩 중...